Europe’s largest medicinal cannabis registry, Project Twenty21, is beginning to gather pace. Steve Jones spoke to Drug Science chief executive David Badcock ahead of the publication of its first data set.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

In late February, the first data from what has been touted as Europe’s largest medicinal cannabis recruitment registry, Project Twenty21, is expected to be released.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...